Literature DB >> 16298907

F2-isoprostanes as markers of oxidative stress in vivo: an overview.

Ginger L Milne1, Erik S Musiek, Jason D Morrow.   

Abstract

The isoprostanes are a unique series of prostaglandin-like compounds formed in vivo via a non-enzymatic mechanism involving the free radical-initiated peroxidation of arachidonic acid. This article summarizes selected aspects regarding current knowledge of these compounds and their value as markers of oxidative injury. Novel aspects related to the biochemistry of isoprostane formation are discussed and methods by which these compounds can be analysed and quantified are summarized. A considerable portion of this article examines the utility of F(2)-isoprostanes as markers of oxidant injury in vivo. Numerous studies carried out over the past decade have shown that these compounds are extremely accurate measures of lipid peroxidation and have illuminated the role of oxidant injury in a number of human diseases including atherosclerosis, Alzheimer's disease and pulmonary disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298907     DOI: 10.1080/13547500500216546

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  96 in total

Review 1.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Intra-person variation of urinary biomarkers of oxidative stress and inflammation.

Authors:  Xiaoyan Wu; Hui Cai; Yong-Bing Xiang; Qiuyin Cai; Gong Yang; Dake Liu; Stephanie Sanchez; Wei Zheng; Ginger Milne; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

Review 3.  A critical review of assays for hazardous components of air pollution.

Authors:  Henry Jay Forman; Caleb Ellicott Finch
Journal:  Free Radic Biol Med       Date:  2018-01-31       Impact factor: 7.376

4.  Feline urinary F2-isoprostanes measured by enzyme-linked immunoassay and gas chromatography-mass spectroscopy are poorly correlated.

Authors:  Andrew D Woolcock; Ashley Leisering; Pierre Deshuillers; Janet Roque-Torres; George E Moore
Journal:  J Vet Diagn Invest       Date:  2020-07-05       Impact factor: 1.279

Review 5.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

6.  Isoprostanes.

Authors:  L Jackson Roberts; Ginger L Milne
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

7.  Quantification of fatty acid oxidation products using online high-performance liquid chromatography tandem mass spectrometry.

Authors:  Bruce S Levison; Renliang Zhang; Zeneng Wang; Xiaoming Fu; Joseph A DiDonato; Stanley L Hazen
Journal:  Free Radic Biol Med       Date:  2013-03-14       Impact factor: 7.376

8.  Time course of intermittent hypoxia-induced impairments in resistance artery structure and function.

Authors:  Nathan R Philippi; Cynthia E Bird; Noah J Marcus; E Burt Olson; Naomi C Chesler; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2009-12-05       Impact factor: 1.931

9.  Obesity is not associated with contrast nephropathy.

Authors:  Navin Jaipaul; Rendell Manalo; Seyed-Ali Sadjadi; James McMillan
Journal:  Ther Clin Risk Manag       Date:  2010-05-25       Impact factor: 2.423

Review 10.  Systems analysis of protein modification and cellular responses induced by electrophile stress.

Authors:  Aaron T Jacobs; Lawrence J Marnett
Journal:  Acc Chem Res       Date:  2010-05-18       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.